# FDA Inspection 1256367 - IndeCon, Inc. - December 12, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/indecon-inc/d75d58fc-1bd4-44ad-bbe6-a64f8feebaba
Source feed: FDA_Inspections

> FDA Inspection 1256367 for IndeCon, Inc. on December 12, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256367
- Company Name: IndeCon, Inc.
- Inspection Date: 2024-12-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 998132 - 2016-11-22](https://www.globalkeysolutions.net/records/fda_inspections/indecon-inc/81c813a0-59c5-4f9b-a601-bdf071cef1cf)
- [FDA Inspection 880573 - 2014-05-29](https://www.globalkeysolutions.net/records/fda_inspections/indecon-inc/d7e6e7b4-204c-4ccf-939f-20039f8ce5e7)

Company: https://www.globalkeysolutions.net/companies/indecon-inc/4e69c625-7949-4a8f-8792-1c94387f1de7

Office: https://www.globalkeysolutions.net/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9